Who is sponsoring NCT02758275?

NCT02758275 is sponsored by Universidad Industrial de Santander.

What drugs are being tested in NCT02758275?

Interventions in NCT02758275: Teaching: Individual (5606).

What condition does NCT02758275 study?

NCT02758275 studies Diabetes Mellitus, Type 2, Hypertension.

Is NCT02758275 still recruiting?

NCT02758275 is currently completed. Last updated 19 October 2017.

Last reviewed 2017-10-19 · How we verify

NCT02758275: ENURSIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and/or Diabetes Type 2

Completed NA Last updated 19 October 2017

What this trial tests

NA trial testing Teaching: Individual (5606) in Diabetes Mellitus, Type 2 in 200 participants. Completed in 15 September 2017.

Timeline

28 April 2016

Primary endpoint
21 July 2016

15 September 2017

Quick facts

Lead sponsor	Universidad Industrial de Santander
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	200
Start date	28 April 2016
Primary completion	21 July 2016
Estimated completion	15 September 2017
Sites	2 locations across Colombia

Drugs / interventions tested

Teaching: Individual (5606)

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Hypertension — all drugs for Hypertension →

Sponsor

Universidad Industrial de Santander

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 2 or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to improve the adherence of therapeutic regimen in people with hypertension arterial and/or diabetes mellitus type 2. Our hypothesis is the nursing intervention "Teaching: Individual", is more effective to increase adherence of therapeutic regimen in people with hypertension arterial and/or diabetes mellitus type 2, than usual care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

"Teaching: Individual" to increase adherence to therapeutic regimen in people with hypertension and type-2 diabetes: protocol of the controlled clinical trial ENURSIN.
Romero Guevara SL, Parra DI, Rojas LZ. · · 2019 · cited 6× · PMID 31171916 · DOI 10.1186/s12912-019-0344-0
"Teaching:Individual" to Increase Adherence to Therapeutic Regimen in People with Hypertension and Type-2 Diabetes: Randomized Controlled Trial ENURSIN
Parra DI, Guevara SLR, Sánchez LZR. · · 2019 · DOI 10.21203/rs.2.18001/v1

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Universidad Industrial de Santander trials

Trials by the same sponsor.

NCT07149753 — Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis · Phase 1 · not yet recruiting
NCT06614517 — Bird Watching to Reduce Stress in University Students · NA · completed
NCT03675958 — Immediate Effect of Johnstone's Pressure Splint Added to Stretching on the Spasticity in Cerebrovascular Disease. · NA · unknown
NCT03423914 — Efficacy of Expressive Writing in Mothers of Preterm Infants · NA · unknown
NCT03070158 — Affective Bonding in Mothers and Their Premature Newborn · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02758275 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Industrial de Santander
Last refreshed: 19 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02758275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing